In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs), including:
- a review of the relevant guidance
- HPAPI classification systems
- safety processes to minimize exposure risk
- equipment and methods to prevent cross-contamination
- how to ensure GMP compliance for regulatory submissions
DOWNLOAD THE ISSUE NOW!
